FDA-approved Hormones & metabolism

Insulin analogs

Insulin analogs is an insulin receptor agonist. It is filed in this library under hormones & metabolism, a navigation topic rather than a statement of where it acts. As a regulatory matter it has at least one product approved by the FDA.

Regulatory status

Insulin analogs has an FDA-approved product on the U.S. market, marketed as Admelog under application BLA209196.

The current label is held by Sanofi-Aventis U.S.

LLC.

From the FDA label

What Insulin analogs is approved to treat

is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.Quoted from the FDA-approved prescribing information

The evidence

What has actually been published

One source on Insulin analogs, resolved to its journal of record. The title is listed so you can judge the evidence rather than take a summary on trust.

Nearby

Other peptides acting on hormones & metabolism

Markers on this pathway

What is measured when blood sugar and insulin is assessed

Insulin analogs' FDA-approved label indicates it for glycemic control or for a glucose emergency. These are the markers clinicians use when assessing blood sugar and insulin. They are listed here so you can read about them, not as a statement that Insulin analogs changes any of them.

Not sure what applies to you?

A 60-second questionnaire, reviewed by a U.S.-licensed physician.

Find my protocol

Educational reference only. This page explains what has been published about Insulin analogs. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.

Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.

All 150 peptides